| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |